ArticleBBA clinical2017
Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients.
Kay Reen Ting et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled ittrialcites it